Search Results 21-30 of 16798 for Imiglucerase

  1. Hematology - Clinical trials

    Hematology — Learn about innovative diagnosis and treatment options for blood diseases, including cancers, at Mayo Clinic.

  2. LY4268989 (MORF-057) Co-Administered With Mirikizumab In Adults With Moderately To Severely Active Ulcerative Colitis: - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  3. Alemtuzumab (intravenous route) - Side effects & uses - Mayo Clinic

    Alemtuzumab injection is used to treat the relapsing forms of multiple sclerosis (MS), including relapsing-remitting disease and active secondary progressive ...

  4. Crohn's disease - Doctors and departments - Mayo Clinic

    Radiologists at Mayo Clinic were instrumental in developing novel bowel imaging techniques, including magnetic resonance (MR) and CT enterography. Current ...

  5. A Study To Evaluate Efficacy Of Remibrutinib Compared To Dupilumab At Early Timepoints In Adults With Chronic Spontaneous Urticaria Inadequately Controlled By Second Generation H1-antihistamines - Mayo Clinic

    Clinical Trials · A Study To Evaluate Efficacy Of Remibrutinib Compared To Dupilumab At Early Timepoints In Adults With Chronic Spontaneous Urticaria ...

  6. Amphotericin b cholesteryl sulfate complex (intravenous route) - Side effects & dosage - Mayo Clinic

    Amphotericin B cholesteryl complex is an antifungal medicine. It is used to help the body overcome serious infections, such as aspergillosis, that are caused by ...

  7. Exagamglogene autotemcel (intravenous route) - Side effects & uses - Mayo Clinic

    Exagamglogene autotemcel injection is used to treat sickle cell disease (red blood cell disease) in patients who have frequent vaso-occlusive crisis. It is also ...

  8. Aflibercept-yszy (intraocular route) - Side effects & uses - Mayo Clinic

    Aflibercept-yszy injection is used to treat neovascular (wet) age-related macular degeneration (AMD). AMD is a disorder of the retina in the eye that causes ...

  9. Hematology - Clinical trials

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  10. Glatiramer (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Glatiramer injection is used to treat relapsing-forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and ...